Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL

被引:289
作者
Hergovich, A [1 ]
Lisztwan, J [1 ]
Barry, R [1 ]
Ballschmieter, P [1 ]
Krek, W [1 ]
机构
[1] Friedrich Miescher Inst, CH-4058 Basel, Switzerland
关键词
D O I
10.1038/ncb899
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Von Hippel-Lindau (VHL) tumour suppressor gene inactivation is linked to the development of haemangioblastomas in the central nervous system and retina, often in association with other tumours, such as clear-cell carcinomas of the kidney and phaeochromocytomas. Here we show that the VHL protein (pVHL) is a microtubule-associated protein that can protect microtubules from depolymerization in vivo. Both the microtubule binding and stabilization functions of pVHL depend on amino acids 95-123 of pVHL, a mutational 'hot-spot' in VHL disease. From analysis of naturally occurring pVHL mutants, it seems that only point mutations such as pVHL(Y98H) and pVHL(Y112H) (that predispose to haemangioblastoma and phaeochromocytoma, but not to renal cell carcinoma) disrupt pVHL's microtubule-stabilizing function. Our data identify a role for pVHL in the regulation of microtubule dynamics and potentially provide a link between this function of pVHL and the pathogenesis of haemangioblastoma and phaeochromocytoma in the context of VHL disease.
引用
收藏
页码:64 / 70
页数:7
相关论文
共 42 条
[1]   Software and database for the analysis of mutations in the VHL gene [J].
Béroud, C ;
Joly, D ;
Gallou, C ;
Staroz, F ;
Orfanelli, MT ;
Junien, C .
NUCLEIC ACIDS RESEARCH, 1998, 26 (01) :256-258
[2]   Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activity [J].
Blankenship, C ;
Naglich, JG ;
Whaley, JM ;
Seizinger, B ;
Kley, N .
ONCOGENE, 1999, 18 (08) :1529-1535
[3]  
Bradley JF, 1999, AM J MED GENET, V87, P163, DOI 10.1002/(SICI)1096-8628(19991119)87:2<163::AID-AJMG7>3.0.CO
[4]  
2-A
[5]  
BRANCH H, 1995, HUM GENET, V95, P551
[6]  
Brauch H, 2000, CANCER RES, V60, P1942
[7]   GERMLINE MUTATIONS IN THE VONHIPPEL-LINDAU DISEASE TUMOR-SUPPRESSOR GENE - CORRELATIONS WITH PHENOTYPE [J].
CHEN, F ;
KISHIDA, T ;
YAO, M ;
HUSTAD, T ;
GLAVAC, D ;
DEAN, M ;
GNARRA, JR ;
ORCUTT, ML ;
DUH, FM ;
GLENN, G ;
GREEN, J ;
HSIA, YE ;
LAMIELL, J ;
LI, H ;
WEI, MH ;
SCHMIDT, L ;
TORY, K ;
KUZMIN, I ;
STACKHOUSE, T ;
LATIF, F ;
LINEHAN, WM ;
LERMAN, M ;
ZBAR, B .
HUMAN MUTATION, 1995, 5 (01) :66-75
[8]   Contrasting effects on HIF-1α regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease [J].
Clifford, SC ;
Cockman, ME ;
Smallwood, AC ;
Mole, DR ;
Woodward, ER ;
Maxwell, PH ;
Ratcliffe, PJ ;
Maher, ER .
HUMAN MOLECULAR GENETICS, 2001, 10 (10) :1029-1038
[9]   Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein [J].
Cockman, ME ;
Masson, N ;
Mole, DR ;
Jaakkola, P ;
Chang, GW ;
Clifford, SC ;
Maher, ER ;
Pugh, CW ;
Ratcliffe, PJ ;
Maxwell, PH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (33) :25733-25741
[10]   Immunostaining of the von Hippel-Lindau gene product in normal and neoplastic human tissues [J].
Corless, CL ;
Kibel, AS ;
Iliopoulos, O ;
Kaelin, WG .
HUMAN PATHOLOGY, 1997, 28 (04) :459-464